Navigation Links
Omthera Announces Waiver of Lock-Up Restriction
Date:7/11/2013

PRINCETON, N.J., July 11, 2013 /PRNewswire/ -- Omthera Pharmaceuticals, Inc. (the "Company") announced today that BofA Merrill Lynch and Barclays, the lead book-running managers in the Company's recent public sale of 8,000,000 shares of common stock, is waiving a lock-up restriction with respect to all outstanding shares of the Company's common stock held by the shareholders, officers and directors of the Company in connection with certain dispositions related to the Company's announced definitive merger agreement with an affiliate of AstraZeneca PLC.  The waiver will take effect on July 15, 2013, and the shares may be disposed of on or after such date in accordance with the terms of the waiver.

This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.

About Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for dyslipidemia and the treatment of cardiovascular disease. Epanova™, currently the Company's sole product candidate, is a late-stage, novel, omega-3 free fatty acid composition that meaningfully reduces triglycerides, improves other key lipid parameters and is expected to increase patient convenience with 2-gram once-a-day dosing with or without meals. Epanova™ is a coated soft gelatin capsule containing a complex mixture of polyunsaturated free fatty acids derived from fish oils, including multiple long-chain omega-3 and omega-6 fatty acids, with EPA, DHA, and docosapentaenoic acid being the most abundant forms of omega-3 fatty acids. The Company has co
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
2. Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm
3. Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
4. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
5. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
6. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
7. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
8. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results
11. UM Ventures Announces Collaboration Between UM School Of Medicines Dr. Frank Robb and Fina Biosolutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Codman Neuro*, part of DePuy Synthes Companies of ... embolic coils for the treatment of brain aneurysms, supported ... stability and provide an optimized detachment zone for coils ... Society of NeuroInterventional Surgery (SNIS) 12 th Annual ... finishing coils used during a minimally invasive endovascular procedure ...
(Date:7/28/2015)... Amgen (NASDAQ: AMGN ) announced that ... share dividend for the third quarter of 2015. The ... all stockholders of record as of the close of ... Amgen Amgen is committed to unlocking the potential of ... developing, manufacturing and delivering innovative human therapeutics. This approach ...
(Date:7/28/2015)... BILLERICA, Mass. , July 28, 2015  Insulet ... insulin pump technology with its OmniPod ® Insulin ... has been appointed to Insulet,s Board of Directors. ... of top-tier healthcare experience to the Insulet Board. She ... of the Joslin Diabetes Center, the world,s largest diabetes ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3
... Bionovo, Inc. (Nasdaq: BNVI ) announced today that ... fiscal year 2009 ended September 30, 2009 on Thursday, November ... web cast to review the financial results on Thursday, November ... access the call by dialing (800) 860-2442 or (412) 858-4600, ...
... AMSTERDAM, October 29 Amsterdam Molecular,Therapeutics ... entered into a development and commercialization agreement for,LPLchip(TM), a ... lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as,a ... In June of this year AMT ...
Cached Medicine Technology:AMT Starts Development LPLChip(TM) With Progenika 2AMT Starts Development LPLChip(TM) With Progenika 3
(Date:7/29/2015)... ... July 29, 2015 , ... ... entered into a partnership with 247Ergo, an ergonomics specialty firm. Purpose of the ... projects that the companies undertake could improve worker mobility, functionality and fitness levels. ...
(Date:7/29/2015)... Estates, IL (PRWEB) , ... July 29, 2015 , ... ... both benefit from two new products on Mercola.com: a vertical “garden tower” and enhanced ... which can be squeezed into small corners on a porch, balcony, or rooftop – ...
(Date:7/29/2015)... ... 29, 2015 , ... Indiana is known for basketball, the boyhood home of ... Indianapolis, which plans to expand across the state. , Ray Kennedy, owner of the ... in business and we should double our first year’s revenue. More importantly, we ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... seeking funding for a study on the potentially lifesaving impact of removing aluminum ... . , The research proposal is based on a successful pilot study ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth ... in Sarasota to be chosen by the manufacturer to offer and perform ... injectable, non-invasive way to treat and eliminate double chin fat,” Dr. Callahan explained. ...
Breaking Medicine News(10 mins):Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3
... was diagnosed with lung cancer has won $ 1 million in ... suffering from an inoperable lung cancer. ,Doctors have given ... At this juncture, he has won this lottery. But the irony ... paid $50,000 in annual installments over twenty years. ,Schenk ...
... University in Chicago claim that men who have undergone ... type// of dementia. This study was published in Cognitive ... on 106 men. Out of this, 25 developed a ... undergone vasectomy. According to the chief scientist of this ...
... new study suggests that patients who develop Parkinson's ... history includes alcohol// abuse may be more likely ... of medications used to treat their condition. ... hypersexuality, binge eating and pathological gambling—have been associated ...
... People who have multiple sclerosis (MS) for 10 years and have ... they// have “benign MS” and that their symptoms will likely not ... A new study shows that unfortunately this may not be correct. ... nearly half of those whose MS was benign at 10 years, ...
... Medicare coverage for colorectal cancer screening has increased, there ... a report published recently, some of these disparities are ... ,Colorectal cancer is the third most common ... with approximately 145,290 new cases in 2005, according to ...
... test that can distinguish between a pair of nearly ... treatment. ,Their report is published this week ... the National Academy of Sciences. ,"This simple ... quickly implemented in the clinic to benefit patients by ...
Cached Medicine News:Health News:Compulsive Gambling Linked to Parkinson's Disease Medications 2Health News:Disparities in Colon Cancer Screening Remain Among Medicare Patients 2Health News:A New Two-gene Test to Discern Similar Gastrointestinal Cancers 2
This is adapted to microplate or card....
ScanGel® Incubator...
... The ID-Micro Typing System™ ... for a broad range of ... include antibody screening and identification, ... phenotyping, compatibility testing, reverse serum ...
... 120 Mini-Vertical Gel System simplifies the process of ... format. It is able to run four gels ... To maximize utility and throughput, the 120 mini-vertical ... gels (W x L) at one time. The ...
Medicine Products: